Major depressive disorder (MDD) is a debilitating condition that affects more than 246 million people worldwide, yet scientists have struggled to identify consistent brain markers that could improve ...

In older adults with asthma, major depressive disorder was linked to poorer control and quality of life, partly via negative ...

Major depressive disorder (MDD) is a debilitating condition that affects more than 246 million people worldwide, yet ...

No statistically significant change in MADRS total score was observed with solriamfetol vs placebo in the overall study population. Topline results were announced from a phase 3 trial evaluating ...

Patients with depressive symptoms and asthma had elevated levels of serum brain-derived neurotrophic factor in association ...

A team of researchers, through a collaborative study, now points to functional connectome uniqueness (an individual-level ...

Intra-Cellular Therapies’ surging antipsychotic Caplyta has scored again with remarkable trial results, fueling its bid for a third and potentially most lucrative indication—major depressive disorder ...

The wearable device delivers electrical impulses through a headset that can be administered by the patient at home under physician oversight.